A landmark study published in Cell Press Blue and highlighted by ScienceDaily on June 2, 2026 has produced one of the most significant findings in developmental pediatrics in recent memory: epigenetic changes present at birth influence how a baby's gut microbiome develops during the first year of life — and certain combinations of those epigenetic patterns and gut bacteria are directly linked to early signs of autism spectrum disorder (ASD) and ADHD by age three.
Most importantly, the research found that specific beneficial bacteria — most notably Lachnospira — can step in during that critical first year to mitigate epigenetic risk and help protect brain health. This is not a theoretical connection. It is an empirically observed protective mechanism, operating in human infants, that points toward interventions that parents, pediatricians, and neonatologists can potentially act on.
